Found: 24
Select item for more details and to access through your institution.
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02585-z
- By:
- Publication type:
- Article
The Impact of Age and Gender on Hematopoietic Stem Cells and Immune Contexture of the Bone Marrow Microenvironment.
- Published in:
- Cells Tissues Organs, 2020, v. 209, n. 4-6, p. 209, doi. 10.1159/000510774
- By:
- Publication type:
- Article
Combinatorial Influence of Bone Marrow Aspirate Concentrate (BMAC) and Platelet-Rich Plasma (PRP) Treatment on Cutaneous Wound Healing in BALB/c Mice.
- Published in:
- Journal of Burn Care & Research, 2024, v. 45, n. 1, p. 59, doi. 10.1093/jbcr/irad080
- By:
- Publication type:
- Article
Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 5, p. 4120, doi. 10.1002/jcp.29324
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02251-7
- By:
- Publication type:
- Article
Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction: Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00880-w
- By:
- Publication type:
- Article
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
Preventing free radical damage: The significance of including antioxidants in diet to strengthen immunity.
- Published in:
- Open Veterinary Journal, 2024, v. 14, n. 7, p. 1526, doi. 10.5455/OVJ.2024.v14.i7.2
- By:
- Publication type:
- Article
L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01321
- By:
- Publication type:
- Article
Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells.
- Published in:
- Biochemical Society Transactions, 2016, v. 44, n. 2, p. 377, doi. 10.1042/BST20150254
- By:
- Publication type:
- Article
Under hypoxic conditions, MSCs affect the expression and methylation level of survival‐related genes in ALL independent of apoptosis pathways in vitro.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 2, p. 822, doi. 10.1002/bab.2154
- By:
- Publication type:
- Article
Purity of transferred CD8<sup>+</sup> T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.
- Published in:
- Immunology & Cell Biology, 2016, v. 94, n. 8, p. 802, doi. 10.1038/icb.2016.45
- By:
- Publication type:
- Article
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41811-z
- By:
- Publication type:
- Article
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00880-w
- By:
- Publication type:
- Article
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00854-y
- By:
- Publication type:
- Article